SEC Form 4 · accession 0001437749-18-010773
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven D Goldby
Director
Period of report
May 23, 2018
Accepted (ET)
May 25, 2018 · 5:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 23, 2018 | M | 4,286 | $13.65 | A | 46,490 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2,F1,F3 | — | May 23, 2018 | M | 4,286 | D | May 23, 2018 | May 23, 2018 | Common Stock | 4,286 | 0 | D |
Explanation of responses
- F1The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F2The restricted stock units were granted on June 1, 2017.
- F3The restricted stock units vested on May 23, 2018.